Items

• TLC determination of glimepiride and its main impurities in pharmaceuticals (2013-10)

  V. Topić, S. Filipić, G. Popović, K. Nikolić, D. Agbaba, TLC determination of glimepiride and its main impurities in pharmaceuticals, JOURNAL OF LIQUID CHROMATOGRAPHY AND RELATED TECHNOLOGIES, Vol. 36, No. 17, pp. 2422 - 2430, Oct, 2013

• Primena metoda tankoslojne hromatografije i hromatografije na koloni u praćenju sinteze α-tokoferil-lizin estra (2014)

  Ž. Gagić, B. Ivković, K. Nikolić, D. Agbaba, Primena metoda tankoslojne hromatografije i hromatografije na koloni u praćenju sinteze α-tokoferil-lizin estra, Arhiv za farmaciju, Vol. 64, No. 3, pp. 261 - 270, 2014

• Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs (2016)

  Ž. Gagić, B. Ivković, T. Srdic-Rajic, J. Vucicevic, K. Nikolic, D. Agbaba, Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Vol. 88, pp. 59 - 69, 2016

• 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity (2017)

  J. Oluic, K. Nikolic, J. Vucicevic, Z. Gagic, S. Filipic, D. Agbaba, 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity, COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, Vol. 20, No. 4, pp. 292 - 303, 2017

• Molekulsko modelovanje i analiza 3D-strukture farmakofore selektivnih PI3K-α inhibitora kao antitumorskih agenasa (2018)

  M. Jovanović, K. Nikolić, Ž. Gagić, D. Agbaba, Molekulsko modelovanje i analiza 3D-strukture farmakofore selektivnih PI3K-α inhibitora kao antitumorskih agenasa, Arhiv za farmaciju, Vol. 4, No. 68, pp. 860 - 873, 2018

• Design of experiments and Derringer’s desirability function in optimisation and validation of RP-HPLC method for the analysis of enrofloxacin and its impurities (2023-01)

  J. Dokmanović, I. Kasagić-Vujanović, Ž. Gagić, K. Nikolić, M. Čarapić, D. Agbaba, Design of experiments and Derringer’s desirability function in optimisation and validation of RP-HPLC method for the analysis of enrofloxacin and its impurities, Acta Chromatographica , Vol. 1, No. 1, pp. 1 - 11, Jan, 2023

• The synthesis of amino acid analog of vitamin E (2014)

  Ž. Gagić, B. Ivković, J. Vucicević, D. Agbaba, K. Nikolić, The synthesis of amino acid analog of vitamin E, Proceedings, pp. 1149 - 1152, 2014

• QSAR studies and design of new analogs of vitamin E with antiproliferative effect on MCF-7 breast cancer cells (2014)

  Ž. Gagić, K. Nikolić, D. Agbaba, B. Ivković, QSAR studies and design of new analogs of vitamin E with antiproliferative effect on MCF-7 breast cancer cells, Abstract book, 2014

• Monitoring the synthesis and purification of amino acid ester of α-tocopherol (2015)

  Ž. Gagić, K. Nikolic, B. Ivković, S. Filipic, D. Agbaba, Monitoring the synthesis and purification of amino acid ester of α-tocopherol, Book of abstracts, 2015

• Primena hromatografskih metoda u sintezi α-tokoferil-lizin estra (2015-05)

  Ž. Gagić, K. Nikolić, B. Ivković, S. Filipić, D. Agbaba, Primena hromatografskih metoda u sintezi α-tokoferil-lizin estra, Pharmacia, May, 2015

• Application of different in vitro techniques for predicting blood brain barrier pentration of imidazoline receptor ligands (2015-05)

  J. Vučićević, M. Popović, K. Nikolić, S. Filipić, Ž. Gagić, D. Agbaba, Application of different in vitro techniques for predicting blood brain barrier pentration of imidazoline receptor ligands, Abstract book, May, 2015

• Design of new vitamin E derivatives as potential anticancer agents (2015-05)

  Ž. Gagić, K. Nikolić, B. Ivković, S. Filipić, D. Agbaba, Design of new vitamin E derivatives as potential anticancer agents, Abstract book, pp. 123 - 124, May, 2015

• Targeting the PI3K/mTOR pathway as an antitumor strategy: 3D-QSAR study and design of dual PI3K/mTOR inhibitors (2016-07)

  J. Oluic, K. Nikolic, J. Vucicevic, Z. Gagic, S. Filipic, D. Agbaba, Targeting the PI3K/mTOR pathway as an antitumor strategy: 3D-QSAR study and design of dual PI3K/mTOR inhibitors, Book of the abstracts, Jul, 2016

• QSAR modeling and structure based virtual screening for the selection of new PI3K/mTOR inhibitors as potential anticancer agents (2017)

  J. Oluic, K. Nikolić, J. Vucicevic, Ž. Gagić, S. Filipic, D. Agbaba, QSAR modeling and structure based virtual screening for the selection of new PI3K/mTOR inhibitors as potential anticancer agents, CMBEBIH 2017: Proceedings of the International Conference on Medical and Biological Engineering 2017, pp. 379 - 383, 2017

• 3D molecular pharmacophore determination of PI3K-α kinase inhibitors (2018)

  Ž. Gagić, M. Jovanović, D. Agbaba, K. Nikolic, 3D molecular pharmacophore determination of PI3K-α kinase inhibitors, pp. 97 - 100, 2018

• Ispitivanje citotoksične aktivnosti aminokiselinskih estara vitamina E na ćelijama tumora dojke i pluća (2018-10)

  Ž. Gagić, T. Srdić-Rajić, K. Nikolić, D. Agbaba, Ispitivanje citotoksične aktivnosti aminokiselinskih estara vitamina E na ćelijama tumora dojke i pluća, Arhiv za farmaciju, pp. 391 - 392, Oct, 2018

• QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-7 breast cancer cells (2016-02)

  Ž. Gagić, K. Nikolić, B. Ivković, S. Filipić, D. Agbaba, QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-7 breast cancer cells, JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, Vol. 59, pp. 33 - 44, Feb, 2016